ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0142

Thrombin-Cleaved Osteopontin Fragments Act on Lung CCR2+ Monocytes to Elicit Neutrophil Retention and Hypoxemia in Remote Lung Inflammation After AKI

Session Information

  • AKI: Mechanisms - 1
    November 06, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Ojha, Rupal, Washington University in St Louis, St. Louis, Missouri, United States
  • Komaru, Yohei, Tokyo Daigaku, Bunkyo, Tokyo, Japan
  • Ning, Liang, Washington University in St Louis, St. Louis, Missouri, United States
  • Underhill, Hannah Jane, Washington University in St Louis, St. Louis, Missouri, United States
  • Suresh, Anusha, Washington University in St Louis, St. Louis, Missouri, United States
  • Herrlich, Andreas, Washington University in St Louis, St. Louis, Missouri, United States

Group or Team Name

  • The Herrlich Team.
Background

Acute kidney injury (AKI) complicated by respiratory failure with hypoxemia is common among critically ill patients and associated with high mortality. Previously, we showed that circulating osteopontin (OPN) released only from the injured kidney during AKI causes remote lung inflammation with hypoxemia (Khamissi Sci Adv 2022). In our latest study, we show that AKI-induces blood flow impeding lung capillary neutrophil retention that is initiated by the neutrophil chemoattractant CXCL2, likely derived from CCR2 monocytes. This perfusion impediment causes a ventilation-perfusion mismatch and hypoxemia (Komaru JCI 2025).

Methods

We used OPN-KI mice which carry a point mutation that renders OPN uncleavable by thrombin. Mouse OPN proteins- OPN-FL, OPN-N, OPN-C, and uncleavable OPN-KI were expressed and purified from HEK293T cells. These biologically active proteins were injected into wt mice with mild AKI. CCR2 monocyte-derived peritoneal macrophages were isolated from wt mice, treated with OPN-N+C and analyzed for CXCL2 production.

Results

We now show that OPN targets CCR2 monocytes via its two thrombin cleaved fragments, OPN-N and OPN-C. OPN-KI mice showed kidney injury like wt controls but are protected from remote lung inflammation, showing that OPN acts via its fragments in vivo. Only injection of both OPN fragments, OPN-N + OPN-C, into wt mice with mild AKI induced the full severe remote lung inflammation phenotype comparable to OPN-FL injection. OPN-KI injection was ineffective. Consistent with this, only OPN-N+C effectively induced CXCL2 production in CCR2 monocyte-derived peritoneal macrophages in vitro, suggesting that lung CCR2 monocytes are indeed direct target cells of both OPN fragments.

Conclusion

Our findings show that OPN cleavage is necessary, and both OPN fragments are the key mediators of AKI induced remote lung inflammation. These fragments act on CCR2 monocytes to induce CXCL2 production, elicit neutrophil retention, causing a ventilation perfusion mismatch and hypoxemia. This implies that lung CCR2 monocytes or OPN fragments could be potential therapeutic targets to prevent AKI induced remote lung inflammation.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)